Author: OurCrowd

[Syqe in Globes] Israeli cannabis inhaler company Syqe targets US

Dec 1, 2016 |

Syqe’s CEO has told “Bloomberg” that the company expects approval in other countries with the US “the obvious target.” Earlier this week, Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) announced that it had signed a cooperation and marketing agreement with the Israeli company Syqe Medical to market the world’s first cannabis inhaler. Teva will start distributing the inhaler for pain treatment in Israel in 2017 and Syqe’s CEO Perry Davidson has told “Bloomberg” that it is seeking approval in other countries. “Israel is clearly just the start,” he said. “We expect to be approved for use in other countries in due course. The US, as the biggest medical cannabis market, is an obvious target.” Read more on Globes...

Read More

[Syqe in Bloomberg] Israeli cannabis inhaler may get tested with opium poppy next

Nov 30, 2016 | ,

The inhaler Teva Pharmaceuticals Ltd. will start distributing in Israel to treat pain with cannabis next year may get tested for other plants, including the opium poppy, by developer Syqe Medical. Syqe, which manufactures the device, will try loading it with opium and other painkilling substances as well as consider selling it in its current cannabis-dispensing form — the one Teva agreed to market — beyond Israel, according to the Tel Aviv-based company’s founder. Read more on Bloomberg...

Read More

[Morphisec in PR Newswire] Morphisec introduces VDI security solution to innovative moving target defense product

Nov 29, 2016 |

Morphisec, pioneer of Moving Target Defense (MTD) technology and leading provider of endpoint threat prevention solutions, today announces it has added Morphisec Virtual Desktop Infrastructure (VDI) Security Solution to its growing list of security offerings. “Virtual Desktop Infrastructure (VDI) is notoriously difficult to adequately protect from cyberattacks as it is highly sensitive to the performance impact of security products,” said Morphisec CEO Ronen Yehoshua. “The trend toward more and more unknown advanced attacks demands the addition of more security layers, which further exacerbates this situation. Morphisec not only stops these attacks, but it does so with zero CPU consumption.” Read more on PR Newswire...

Read More
[PRESS RELEASE] OurCrowd Opens Singapore Office, Appoints Denes Ban Managing Partner Asia

[PRESS RELEASE] OurCrowd Opens Singapore Office, Appoints Denes Ban Managing Partner Asia

Nov 28, 2016 |

Jerusalem/Singapore– November 28, 2016 – OurCrowd, a global leader in equity crowdfunding, announced today that it has opened an office in Singapore, its seventh worldwide, to serve the growing community of Asian investors interested in funding early stage high-growth companies. It has appointed Denes Ban, a successful entrepreneur and technology executive, as Managing Partner Asia and head of OurCrowd’s Singapore Management company. Read more...

Read More